Pharmaceuticals

Innovative ETFs Channel

Biotech ETFs Strengthen After Judge Blocks Trump’s Drug Pricing Rule

By Max ChenJuly 9, 2019

Innovative ETFs Channel

AbbVie, Allergan Deal Puts Spotlight on Pharmaceutical ETFs

By Max ChenJune 25, 2019

Innovative ETFs Channel

Legal Troubles Beset Pharmaceutical Sector ETFs

By Max ChenMay 14, 2019

Innovative ETFs Channel

Pharmaceutical ETFs Catch Healthcare Contagion

By Max ChenApril 18, 2019

Innovative ETFs Channel

Pharmaceutical ETFs Break Out on Horizon Pharma’s Positive Drug Results

By Max ChenFebruary 28, 2019

Core ETF Channel

Healthcare ETFs Slip After Abbot Lab’s Revenue Miss, Weak Outlook

By Max ChenJanuary 23, 2019

Equity ETFs

ETF Plays for a Divided Midterm Elections

By Max ChenOctober 22, 2018

Equity ETFs

Pharmaceutical ETFs Could Maintain Their Momentum

By Max ChenSeptember 6, 2018

New ETFs

Loncar Debuts ETF to Play China’s Biotech, Pharma Companies

By Max ChenAugust 15, 2018

Equity ETFs

Biotech ETFs Rally as Illumina Tops Q2 Expectations

By Max ChenJuly 31, 2018

Equity ETFs

July Could Be a Volatile Month for Pharma ETFs

By Max ChenJuly 3, 2018

Equity ETFs

Amazon ETFs Mostly Down After PillPack Acquisition

By Ben HernandezJune 28, 2018

Equity ETFs

6 Top Healthcare ETFs Rally as Trump Vows End to ‘Global Freeloading’

By Max ChenMay 11, 2018

Alternative ETFs

Direxion Resuscitates Leveraged Pharmaceutical ETF

By Max ChenNovember 15, 2017

Equity ETFs

Biotech, Pharma ETFs Leave Pricing Drama Behind

By Max ChenSeptember 15, 2017

Equity ETFs

Drug Makers, Pharma ETFs Face a Tough Earnings Season

By Max ChenApril 24, 2017

Equity ETFs

Alternative ETF Options to Hedge Trump Risk on Obamacare

By Tom LydonMarch 7, 2017

Equity ETFs

Healthcare ETFs Are Latest Victim to Trump

By Max ChenJanuary 11, 2017